Medtronic and Boston Scientific, which both have major cardiac-device operations in Minnesota ... devices physicians can ...

The global cardiac mapping market stood at US$ 3 billion in 2023, and the global market is projected to reach US$ 5.5 billion ...

Following cardiac catheterization, patients with ST-segment elevation myocardial infarction (STEMI) have a higher risk of short-term mortality than patients with non-STEMI (NSTEMI), who have a ...

TCAI is the first to use Medtronic’s Affera mapping and ablation system with a Sphere-9 catheter since it received FDA ...

"This all-in-one, first-of-its-kind catheter allows physicians to map, ablate and ... for the treatment of heart arrhythmias continues to advance, the Texas Cardiac Arrhythmia Institute is ...

A new technique that combines blood-flow measurements in a patient’s heart with an MRI can improve a doctor’s ability to diagnose coronary artery disease, according to researchers at the University of ...

Right heart catheterization (RHC) is essential for accurate PAH diagnosis but is underutilized, with only 75% of patients undergoing the procedure at diagnosis. Factors increasing RHC likelihood ...

"As global innovation for the treatment of heart arrhythmias ... in-us-to-use-fda-approved-mapping-and-dual-energy-ablation-catheter-302321221.html SOURCE Texas Cardiac Arrhythmia Institute ...

4, 2024 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first in the nation to use an all-in-one high-density ...